237 related articles for article (PubMed ID: 7031015)
21. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
22. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
23. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
24. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
25. Aromatase inhibitors: rationale for use following antiestrogen therapy.
Yue W; Santen RJ
Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
[TBL] [Abstract][Full Text] [Related]
26. Future directions in the treatment of hormone-sensitive advanced breast cancer: the RAD001 (Everolimus)-letrozole clinical program.
Lane HA; Lebwohl D
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S18-25. PubMed ID: 16730273
[TBL] [Abstract][Full Text] [Related]
27. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
[TBL] [Abstract][Full Text] [Related]
28. Steroid receptors in breast tumors--current status.
McGuire WL; Zava DT; Horwitz KB; Chamness GC
Curr Top Exp Endocrinol; 1978; 3():93-129. PubMed ID: 350504
[No Abstract] [Full Text] [Related]
29. Estrogen and progesterone receptor proteins in breast cancer.
Edwards DP; Chamness GC; McGuire WL
Biochim Biophys Acta; 1979 Dec; 560(4):457-86. PubMed ID: 391286
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
31. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
32. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
33. Peroxidase activity as a marker for estrogenicity: studies in uterus and mammary tumors.
Levy J; Liel Y; Glick SM
Isr J Med Sci; 1981; 17(9-10):970-5. PubMed ID: 7309486
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
Rorke EA; Katzenellenbogen BS
Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
[No Abstract] [Full Text] [Related]
35. Physiological and pharmacological effects of estrogens in breast cancer.
Leclercq G; Heuson JC
Biochim Biophys Acta; 1979 Dec; 560(4):427-55. PubMed ID: 391285
[TBL] [Abstract][Full Text] [Related]
36. Regulatory mechanisms in breast cancer. Estrogen and progesterone receptors.
Martin MB; Saceda M; Lindsey RK
Cancer Treat Res; 1991; 53():273-88. PubMed ID: 1672082
[No Abstract] [Full Text] [Related]
37. [Hormone dependence and the basis of hormone therapy in breast cancer].
Martin PM
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):183-99. PubMed ID: 209076
[No Abstract] [Full Text] [Related]
38. Biochemical basis of breast cancer treatment by androgens and progestins.
Rochefort H
Prog Clin Biol Res; 1984; 142():79-95. PubMed ID: 6538685
[No Abstract] [Full Text] [Related]
39. [Antiestrogen action of progesterone in the breast].
Mauvais-Jarvis P; Kuttenn F; Gompel A; Benotmane A
Pathol Biol (Paris); 1987 Sep; 35(7):1081-6. PubMed ID: 3313217
[TBL] [Abstract][Full Text] [Related]
40. New strategies for investigating antiestrogen action in breast cancer.
McGuire WL
Cancer Res; 1982 Aug; 42(8 Suppl):3420s-3423s. PubMed ID: 6177403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
